Test for early detection of cervical cancer.

Zetiq Technologies, a subsidiary of Bio-Light, has successfully completed the first arm of its cervicalRelating either to the cervix (the neck of the womb) or to the cervical vertebrae in the neck (cervical spine). cancerAbnormal, uncontrolled cell division resulting in a malignant tumour that may invade surrounding tissues or spread to distant parts of the body. clinical trial, aimed at identifying and diagnosing cervical cancer in biopsies. The goal of the trial was to demonstrate and measure the ability of Zetiq's technology to accurately diagnose the presence of cervical cancer cells and the stage of the disease, including in early stages of malignancy, in cervical biopsies. Read the full story on the Bio-Light website

Filed under:

Continuous improvement requires feedback and your opinions count. Do you have a few minutes to tell us what you think about this site?

Yes
No